Industry Research Reports

Home > Reports > Food & Beverages > Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Industry: Food & Beverages

Published: 2023-05-25

Pages: 88 Pages

Report ld: 1225203

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Biosynthetic Human Milk Oligosaccharides (HMOs) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biosynthetic Human Milk Oligosaccharides (HMOs) market is projected to reach US$ 2153.1 million in 2029, increasing from US$ 459.4 million in 2022, with the CAGR of 24.6% during the period of 2023 to 2029. Demand from Infant Formula and Other Applications are the major drivers for the industry.

The top four global companies of Biosynthetic Human Milk Oligosaccharides (HMOs) are Abbott, Dupont (Inbiose), DSM (Glycom), and Chr. Hansen (Jennewein) dominate the market. Abbott is the largest player, followed by DSM (Glycom). Global Biosynthetic Human Milk Oligosaccharides are mainly produced in North America and Europe, with North America holding about 60% of the market share. In terms of its type, 2'-Fucose lactose and 3-Fucose lactose hold about 90% of the market share. In terms of application, infant formula application occupies an absolutely important market position.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biosynthetic Human Milk Oligosaccharides (HMOs) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Companies, Type, Application and Regions Listed in the Report:
By Company
    Abbott
    Dupont (Inbiose)
    DSM (Glycom)
    Chr. Hansen (Jennewein)
    BASF
    FrieslandCampina

Segment by Type
    2'-FL & 3-FL
    LNT & LNnT, etc.

Segment by Application
    Infant Formula
    Other Applications

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        
    Latin America
        Mexico
        Brazil
        
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Biosynthetic Human Milk Oligosaccharides (HMOs) market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, Biosynthetic Human Milk Oligosaccharides (HMOs) introduction, etc. Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: QYResearch’s Conclusions of Biosynthetic Human Milk Oligosaccharides (HMOs) market based on comprehensive survey.
Chapter 13: Methodology and Data Sources adopted by QYResearch.

 1 Market Overview of Biosynthetic Human Milk Oligosaccharides (HMOs)
    1.1 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Overview
        1.1.1 Biosynthetic Human Milk Oligosaccharides (HMOs) Product Scope
        1.1.2 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Status and Outlook
    1.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Overview by Region 2018 VS 2022 VS 2029
    1.3 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2018-2029)
    1.4 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Historic Market Size by Region (2018-2023)
    1.5 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Forecast by Region (2024-2029)
    1.6 Key Regions, Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029)
        1.6.1 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029)
        1.6.2 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029)
        1.6.3 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029)
        1.6.4 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029)
        1.6.5 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029)

 2 Biosynthetic Human Milk Oligosaccharides (HMOs) Market by Type
    2.1 Introduction
        2.1.1 2'-FL & 3-FL
        2.1.2 LNT & LNnT, etc.
    2.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type: 2018 VS 2022 VS 2029
        2.2.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Historic Market Size by Type (2018-2023)
        2.2.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Type (2024-2029)
    2.3 Key Regions Market Size by Type
        2.3.1 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Breakdown by Type (2018-2029)
        2.3.2 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Breakdown by Type (2018-2029)
        2.3.3 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Breakdown by Type (2018-2029)
        2.3.4 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Breakdown by Type (2018-2029)
        2.3.5 Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Breakdown by Type (2018-2029)

 3 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Overview by Application
    3.1 Introduction
        3.1.1 Infant Formula
        3.1.2 Other Applications
    3.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application: 2018 VS 2022 VS 2029
        3.2.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Historic Market Size by Application (2018-2023)
        3.2.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Application (2024-2029)
    3.3 Key Regions Market Size by Application
        3.3.1 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Breakdown by Application (2018-2029)
        3.3.2 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Breakdown by Application (2018-2029)
        3.3.3 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Breakdown by Application (2018-2029)
        3.3.4 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Breakdown by Application (2018-2029)
        3.3.5 Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Breakdown by Application (2018-2029)

 4 Biosynthetic Human Milk Oligosaccharides (HMOs) Competition Analysis by Players
    4.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Players (2018-2023)
    4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) as of 2022)
    4.3 Date of Key Players Enter into Biosynthetic Human Milk Oligosaccharides (HMOs) Market
    4.4 Global Top Players Biosynthetic Human Milk Oligosaccharides (HMOs) Headquarters and Area Served
    4.5 Key Players Biosynthetic Human Milk Oligosaccharides (HMOs) Product Solution and Service
    4.6 Competitive Status
        4.6.1 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Concentration Rate
        4.6.2 Mergers & Acquisitions, Expansion Plans

 5 Company (Top Players) Profiles
    5.1 Abbott
        5.1.1 Abbott Profile
        5.1.2 Abbott Main Business
        5.1.3 Abbott Biosynthetic Human Milk Oligosaccharides (HMOs) Products, Services and Solutions
        5.1.4 Abbott Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue (US$ Million) & (2018-2023)
        5.1.5 Abbott Recent Developments
    5.2 Dupont (Inbiose)
        5.2.1 Dupont (Inbiose) Profile
        5.2.2 Dupont (Inbiose) Main Business
        5.2.3 Dupont (Inbiose) Biosynthetic Human Milk Oligosaccharides (HMOs) Products, Services and Solutions
        5.2.4 Dupont (Inbiose) Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue (US$ Million) & (2018-2023)
        5.2.5 Dupont (Inbiose) Recent Developments
    5.3 DSM (Glycom)
        5.3.1 DSM (Glycom) Profile
        5.3.2 DSM (Glycom) Main Business
        5.3.3 DSM (Glycom) Biosynthetic Human Milk Oligosaccharides (HMOs) Products, Services and Solutions
        5.3.4 DSM (Glycom) Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue (US$ Million) & (2018-2023)
        5.3.5 Chr. Hansen (Jennewein) Recent Developments
    5.4 Chr. Hansen (Jennewein)
        5.4.1 Chr. Hansen (Jennewein) Profile
        5.4.2 Chr. Hansen (Jennewein) Main Business
        5.4.3 Chr. Hansen (Jennewein) Biosynthetic Human Milk Oligosaccharides (HMOs) Products, Services and Solutions
        5.4.4 Chr. Hansen (Jennewein) Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue (US$ Million) & (2018-2023)
        5.4.5 Chr. Hansen (Jennewein) Recent Developments
    5.5 BASF
        5.5.1 BASF Profile
        5.5.2 BASF Main Business
        5.5.3 BASF Biosynthetic Human Milk Oligosaccharides (HMOs) Products, Services and Solutions
        5.5.4 BASF Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue (US$ Million) & (2018-2023)
        5.5.5 BASF Recent Developments
    5.6 FrieslandCampina
        5.6.1 FrieslandCampina Profile
        5.6.2 FrieslandCampina Main Business
        5.6.3 FrieslandCampina Biosynthetic Human Milk Oligosaccharides (HMOs) Products, Services and Solutions
        5.6.4 FrieslandCampina Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue (US$ Million) & (2018-2023)
        5.6.5 FrieslandCampina Recent Developments

 6 North America
    6.1 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2018-2029)
    6.2 United States
    6.3 Canada

 7 Europe
    7.1 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2018-2029)
    7.2 Germany
    7.3 France
    7.4 U.K.
    7.5 Italy
    7.6 Russia
    7.7 Nordic Countries
    7.8 Rest of Europe

 8 Asia-Pacific
    8.1 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2018-2029)
    8.2 China
    8.3 Japan
    8.4 South Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australia
    8.8 Rest of Asia-Pacific

 9 Latin America
    9.1 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2018-2029)
    9.2 Mexico
    9.3 Brazil
    9.4 Rest of Latin America

 10 Middle East & Africa
    10.1 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2018-2029)
    10.2 Turkey
    10.3 Saudi Arabia
    10.4 UAE
    10.5 Rest of Middle East & Africa

 11 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Dynamics
    11.1 Biosynthetic Human Milk Oligosaccharides (HMOs) Industry Trends
    11.2 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Drivers
    11.3 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Challenges
    11.4 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Restraints

 12 Research Finding /Conclusion

 13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List

List of Tables
    Table 1. Global Market Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Share by Region (2018-2023)
    Table 4. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Type (2018-2023)
    Table 9. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Type (2024-2029)
    Table 11. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Application (2018-2023)
    Table 24. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Application (2024-2029)
    Table 26. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) as of 2022)
    Table 39. Date of Key Players Enter into Biosynthetic Human Milk Oligosaccharides (HMOs) Market
    Table 40. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Key Players Headquarters and Area Served
    Table 41. Biosynthetic Human Milk Oligosaccharides (HMOs) Product Solution and Service
    Table 42. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Abbott Basic Information List
    Table 45. Abbott Description and Business Overview
    Table 46. Abbott Biosynthetic Human Milk Oligosaccharides (HMOs) Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Biosynthetic Human Milk Oligosaccharides (HMOs) Business of Abbott (2018-2023)
    Table 48. Abbott Recent Developments
    Table 49. Dupont (Inbiose) Basic Information List
    Table 50. Dupont (Inbiose) Description and Business Overview
    Table 51. Dupont (Inbiose) Biosynthetic Human Milk Oligosaccharides (HMOs) Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Biosynthetic Human Milk Oligosaccharides (HMOs) Business of Dupont (Inbiose) (2018-2023)
    Table 53. Dupont (Inbiose) Recent Developments
    Table 54. DSM (Glycom) Basic Information List
    Table 55. DSM (Glycom) Description and Business Overview
    Table 56. DSM (Glycom) Biosynthetic Human Milk Oligosaccharides (HMOs) Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Biosynthetic Human Milk Oligosaccharides (HMOs) Business of DSM (Glycom) (2018-2023)
    Table 58. DSM (Glycom) Recent Developments
    Table 59. Chr. Hansen (Jennewein) Basic Information List
    Table 60. Chr. Hansen (Jennewein) Description and Business Overview
    Table 61. Chr. Hansen (Jennewein) Biosynthetic Human Milk Oligosaccharides (HMOs) Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Biosynthetic Human Milk Oligosaccharides (HMOs) Business of Chr. Hansen (Jennewein) (2018-2023)
    Table 63. Chr. Hansen (Jennewein) Recent Developments
    Table 64. BASF Basic Information List
    Table 65. BASF Description and Business Overview
    Table 66. BASF Biosynthetic Human Milk Oligosaccharides (HMOs) Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Biosynthetic Human Milk Oligosaccharides (HMOs) Business of BASF (2018-2023)
    Table 68. BASF Recent Developments
    Table 69. FrieslandCampina Basic Information List
    Table 70. FrieslandCampina Description and Business Overview
    Table 71. FrieslandCampina Biosynthetic Human Milk Oligosaccharides (HMOs) Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Biosynthetic Human Milk Oligosaccharides (HMOs) Business of FrieslandCampina (2018-2023)
    Table 73. FrieslandCampina Recent Developments
    Table 74. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2018-2023) & (US$ Million)
    Table 75. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2024-2029) & (US$ Million)
    Table 76. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2018-2023) & (US$ Million)
    Table 77. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2024-2029) & (US$ Million)
    Table 78. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 79. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2018-2023) & (US$ Million)
    Table 80. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2024-2029) & (US$ Million)
    Table 81. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Region (2018-2023)
    Table 82. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Region (2024-2029)
    Table 83. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 84. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2018-2023) & (US$ Million)
    Table 85. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2024-2029) & (US$ Million)
    Table 86. Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 87. Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2018-2023) & (US$ Million)
    Table 88. Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2024-2029) & (US$ Million)
    Table 89. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Trends
    Table 90. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Drivers
    Table 91. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Challenges
    Table 92. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Restraints
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Regions: 2022 VS 2029
    Figure 4. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of 2'-FL & 3-FL
    Figure 11. Global 2'-FL & 3-FL Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of LNT & LNnT, etc.
    Figure 13. Global LNT & LNnT, etc. Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Share by Type:  2022 & 2029
    Figure 15. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Type (2018-2029)
    Figure 16. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Type (2018-2029)
    Figure 17. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Type (2018-2029)
    Figure 18. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Type (2018-2029)
    Figure 19. Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Type (2018-2029)
    Figure 20. Infant Formula Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 21. Other Applications Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 22. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Share by Application: 2022 & 2029
    Figure 23. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Application (2018-2029)
    Figure 24. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Application (2018-2029)
    Figure 25. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Application (2018-2029)
    Figure 26. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Application (2018-2029)
    Figure 27. Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Application (2018-2029)
    Figure 28. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 29. Global Top 5 and Top 10 Players Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share in 2022
    Figure 30. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Country (2018-2029)
    Figure 31. United States Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 32. Canada Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 33. Germany Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 34. France Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 35. U.K. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 36. Italy Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 37. Russia Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 38. Nordic Countries Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 39. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Region (2018-2029)
    Figure 40. China Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 41. Japan Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 42. South Korea Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 43. Southeast Asia Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 44. India Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 45. Australia Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 46. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Country (2018-2029)
    Figure 47. Mexico Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 48. Brazil Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 49. Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Country (2018-2029)
    Figure 50. Turkey Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 51. Saudi Arabia Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 52. UAE Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2018-2029) & (US$ Million)
    Figure 53. Bottom-up and Top-down Approaches for This Report

Biosynthetic Human Milk Oligosaccharides (HMOs) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biosynthetic Human Milk Oligosaccharides (HMOs) market is projected to reach US$ 2153.1 million in 2029, increasing from US$ 459.4 million in 2022, with the CAGR of 24.6% during the period of 2023 to 2029. Demand from Infant Formula and Other Applications are the major drivers for the industry.

The top four global companies of Biosynthetic Human Milk Oligosaccharides (HMOs) are Abbott, Dupont (Inbiose), DSM (Glycom), and Chr. Hansen (Jennewein) dominate the market. Abbott is the largest player, followed by DSM (Glycom). Global Biosynthetic Human Milk Oligosaccharides are mainly produced in North America and Europe, with North America holding about 60% of the market share. In terms of its type, 2'-Fucose lactose and 3-Fucose lactose hold about 90% of the market share. In terms of application, infant formula application occupies an absolutely important market position.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biosynthetic Human Milk Oligosaccharides (HMOs) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Companies, Type, Application and Regions Listed in the Report:
By Company
    Abbott
    Dupont (Inbiose)
    DSM (Glycom)
    Chr. Hansen (Jennewein)
    BASF
    FrieslandCampina

Segment by Type
    2'-FL & 3-FL
    LNT & LNnT, etc.

Segment by Application
    Infant Formula
    Other Applications

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        
    Latin America
        Mexico
        Brazil
        
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Biosynthetic Human Milk Oligosaccharides (HMOs) market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, Biosynthetic Human Milk Oligosaccharides (HMOs) introduction, etc. Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: QYResearch’s Conclusions of Biosynthetic Human Milk Oligosaccharides (HMOs) market based on comprehensive survey.
Chapter 13: Methodology and Data Sources adopted by QYResearch.

Industry: Food & Beverages

Published: 2023-05-25

Pages: 88 Pages

Report ld: 1225203

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3350.00

Multi Users License

USD 5025.00

Corporate Users License